Complementary and alternative medicine for multiple sclerosis

Multiple Sclerosis

Volumn 14, Issue 8, 2008, Pages 1113-1119

  Schwarz, Stefan ^a   Knorr, C ^a   Geiger, H ^b   Flachenecker, P ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b AMSEL Baden Wuerttemberg   (Germany)

^c Neurological Rehabilitation Center Quellenhof   (Germany)

Author keywords

Amalgam; Complementary medicine; Epidemiology; Multiple sclerosis; Selenium; Therapy; Vitamin

Indexed keywords

ALPHA TOCOPHEROL; AMALGAM; ANTIDEPRESSANT AGENT; ASCORBIC ACID; AZATHIOPRINE; BETA INTERFERON; CORTISONE; ERGOTAMINE; GLATIRAMER; IMMUNOGLOBULIN; NATALIZUMAB; OMEGA 3 FATTY ACID; SELENIUM; SPASMOLYTIC AGENT; VITAMIN B GROUP; ANTIOXIDANT; VITAMIN;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BLADDER DISEASE; CLINICAL ASSESSMENT; DEPRESSION; DIET THERAPY; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HEALTH SURVEY; HOMEOPATHY; HUMAN; INDEPENDENCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MASSAGE; MULTIPLE SCLEROSIS; PATIENT ATTITUDE; PATIENT SATISFACTION; PHYSIOTHERAPY; POPULATION RESEARCH; PSYCHOTHERAPY; RELIGION; SEX DIFFERENCE; WHITE COLLAR WORKER; DIET; DISABILITY; GERMANY; INCOME; MIDDLE AGED; OCCUPATION; QUESTIONNAIRE; UTILIZATION REVIEW; YOGA;

ADULT; ANTIOXIDANTS; COMPLEMENTARY THERAPIES; DIET; DISABILITY EVALUATION; EDUCATIONAL STATUS; FEMALE; GERMANY; HEALTH SURVEYS; HOMEOPATHY; HUMANS; INCOME; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OCCUPATIONS; QUESTIONNAIRES; RELIGION; VITAMINS; YOGA;

EID: 57949105485     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508092808     Document Type: Article

References (28)

1. Barnes, PM, Powell-Griner, E, McFann, K, Nahin, RL. Complementary and alternative medicine use among adults: United States 2002. Advance data from vital and health statistics, No. 343. Hyattsville, Md: National Center for Health Statistics; 2004.
2. Nayak, S, Matheis, RJ, Schoenberger, NE, Shiflett, SC. Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehabil 2003; 17: 181-191.
3. Apel, A, Greim, B, Konig, N, Zettl, UK. Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis. J Neurol 2006; 253: 1331-1336.
4. Shinto, L, Yadav, V, Morris, C, Lapidus, JA, Senders, A, Bourdette, D. The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosis. Complement Ther Med 2005; 13: 264-272.
5. Stuifbergen, AK, Harrison, TC. Complementary and alternative therapy use in persons with multiple sclerosis. Rehabil Nurs 2003; 28: 141-147, 158.
6. Winterholler, M, Erbguth, F, Neundörfer, B. Verwendung paramedizinischer Verfahren durch MS-Patienten - Patientencharakterisierung und Anwendungsgewohnheiten. Fortschr Neurol Psychiatr 1997; 65: 555-561.
7. Fryze, W, Mirowska-Guzel, D, Wiszniewska, M, Darda-Ledzion, L, Czlonkowski, A, Czlonkowska, A. Alternative methods of treatment used by multiple sclerosis patients in Poland. Neurol Neurochir Pol 2006; 40: 386-390.
8. Campbell, DG, Turner, AP, Williams, RM, et al. Complementary and alternative medicine use in veterans with multiple sclerosis: Prevalence and demographic associations. J Rehabil Res Dev 2006; 43: 99-110.
9. Page, SA, Verhoef, MJ, Stebbins, RA, Metz, LM, Levy, JC. The use of complementary and alternative therapies by people with multiple sclerosis. Chronic Dis Can 2003; 24: 75-79.
10. Pucci, E, Cartechini, E, Taus, C, Giuliani, G. Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients. Eur J Neurol 2004; 11: 263-267.
11. Sastre-Garriga, J, Munteis, E, Rio, J, Pericot, I, Tintore, M, Montalban, X. Unconventional therapy in multiple sclerosis. Mult Scler 2003; 9: 320-322.
12. Defining and describing complementary and alternative medicine. Panel on Definition and Description, CAM Research Methodology Conference, April 1995. Altern Ther Health Med 1997; 3: 49-57.
13. Multiple Sclerosis Therapy Consensus Group. Escalating immunomodulatory therapy of multiple sclerosis: Update (September 2006). Nervenarzt 2006; 77: 1506-1518.
14. Henze, T, Rieckmann, P, Toyka, KV. Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society. Eur Neurol 2006; 56: 78-105.
15. Collins, JG. Prevalence of selected chronic conditions: United States 1990-1992. Vital Health Statistics - Series 10: Data from the National Health Survey 1997; 1-89.
16. Rogelberg, SG, Luong, A. Nonresponse to mailed surveys: A review and guide. Curr Direct Psychol Sci 1998; 7: 60-65.
17. Marrie, RA, Hadjimichael, O, Vollmer, T. Predictors of alternative medicine use by multiple sclerosis patients. Mult Scler 2003; 9: 461-466.
18. Walther, EU, Hohlfeld, R. Multiple sclerosis: Side effects of interferon β therapy and their management. Neurology 1999; 53: 1622-1627.
19. Simone, IL, Ceccarelli, A, Tortorella, C, et al. Influence of Interferon β treatment on quality of life in multiple sclerosis patients. Health Qual Life Outcomes 2006; 4: 96.
20. Schwarz, S, Knauth, M, Schwab, S, Walter-Sack, I, Bonmann, E, Storch-Hagenlocher, B. Acute disseminated encephalomyelitis after parenteral therapy with herbal extracts: A report of two cases. J Neurol Neurosurg Psychiatry 2000; 69: 516-518.
21. Göbel, HH, Walther, G, Meuth, M. Fresh cell therapy followed by fatal coma. J Neurol 1986; 233: 242-247.
22. Schwarz, S, Leweling, H. Multiple Sclerosis and Nutrition. Mult Scler 2005; 11: 24-32.
23. 23. Ernst, E. Harmless Herbs? A review of the literature. Am J Med 1998; 104: 170-178.
24. Bjelakovic, G, Nikolova, D, Simonetti, RG, Gluud, C. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet 2004; 364: 1219-1228.
25. Stranges, S, Marshall, JR, Natarajan, R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: A randomized trial. Ann Intern Med 2007; 147: 217-223.
26. National Institutes of Health State-of-the-Science Conference Statement: multivitamin/mineral supplements and chronic disease prevention. Am J Clin Nutr 2007; 85: 257S-264S.
27. Ogden, J, Bavalia, K, Bull, M, et al. I want more time with my doctor": A quantitative study of time and the consultation. Fam Pract 2004; 21: 479-483.
28. Cape, J. Consultation length, patient estimated consultation length and satisfaction with the consultation. Br J Gen Pract 2002; 52: 1004-1006.